Ozturk, H. Et Al. 2022. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. DEVELOPMENTAL CELL , vol.57, no.11 , 1331-1356.

Ozturk, H., Cingoz, H., Tufan, T., Yang, J., Adair, S. J., Tummala, K. S., ... Kuscu, C.(2022). ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. DEVELOPMENTAL CELL , vol.57, no.11, 1331-1356.

Ozturk, Harun Et Al. "ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer," DEVELOPMENTAL CELL , vol.57, no.11, 1331-1356, 2022

Ozturk, Harun Et Al. "ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer." DEVELOPMENTAL CELL , vol.57, no.11, pp.1331-1356, 2022

Ozturk, H. Et Al. (2022) . "ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer." DEVELOPMENTAL CELL , vol.57, no.11, pp.1331-1356.

@article{article, author={Harun Ozturk Et Al. }, title={ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer}, journal={DEVELOPMENTAL CELL}, year=2022, pages={1331-1356} }